Warning letter
Omicron Quimica S.A.: warning letter of Apr 11, 2001
FDA warning letter UCM069544 · Center for Drug Evaluation and Research
Key facts
| Reference number | UCM069544 |
|---|---|
| Company | Omicron Quimica S.A. |
| Subject | CGMP/Manufacturing Facility/Active Pharmaceutical Ingredient |
| Issue date | Apr 11, 2001 |
| Posted date | Apr 11, 2001 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: